The Illogical Growth in NWBO’s Short Interest:
Date // Short Interest // Milestone
01/12/2024 // 45,906,037
12/29/2023 // 46,139,791
12/15/2023 // 45,776,842 // Marketing Application Submitted
11/30/2023 // 46,647,939
11/15/2023 // 49,260,570
10/31/2023 // 55,750,380
10/13/2023 // 54,229,798
09/29/2023 // 52,330,376
09/15/2023 // 50,976,498 // Linda Liau Appointed to Scientific Advisory Board
08/31/2023 // 48,940,579 // Marketing Application Submission Announced within 30-45 days
08/15/2023 // 47,481,115
07/31/2023 // 44,998,078
07/14/2023 // 44,299,486
06/30/2023 // 43,316,947
06/15/2023 // 41,973,714
05/31/2023 // 40,738,041
05/15/2023 // 39,849,483
04/28/2023 // 37,419,389
04/14/2023 // 39,268,663
03/31/2023 // 39,133,732 // Commercial Manufacturing License Issued for Sawston
03/15/2023 // 39,268,213
02/28/2023 // 40,153,956
02/15/2023 // 39,063,970
01/31/2023 // 38,719,541
01/13/2023 // 41,300,593
12/30/2022 // 41,886,273
12/15/2022 // 41,783,315
11/30/2022 // 38,579,908 // Lawsuit Filed Against Market Makers
11/15/2022 // 27,453,945 // Clinical Trial Data Published in JAMA
10/31/2022 // 27,335,566
10/14/2022 // 27,532,363
09/30/2022 // 28,010,880
2022-09-15 // 29,057,926
2022-08-31 // 30,503,372 // Pediatric Investigation Plan Approved
2022-08-15 // 31,424,311
2022-07-29 // 31,803,013
2022-07-15 // 31,231,677 // Application For Commercial Manufacturing License Submitted
2022-06-30 // 32,876,739
2022-06-15 // 33,595,743
2022-05-31 // 31,736,044
2022-05-13 // 29,024,824 // Positive Top-line Data Released
2022-04-29 // 29,604,478
2022-04-14 // 28,766,916
2022-03-31 // 25,661,442
2022-03-15 // 24,381,784
2022-02-28 // 22,051,004
2022-02-15 // 20,060,226 // DCVax Production Commences at Sawston
2022-01-31 // 19,127,664
2022-01-14 // 17,767,836
2021-12-31 // 16,181,973
2021-12-15 // 15,605,232 // Investigational Manufacturing License Issued For Sawston
2021-11-30 // 13,284,932
2021-11-15 // 12,050,197
2021-10-29 // 12,555,107 // HTA License Issued For Sawston
2021-10-15 // 11,381,523
2021-09-30 // 11,412,754
